| Track 1: Molecular and Cellular Immunology |
| Track 1-1: |
Infection, allergies and immune response |
| Track 1-2: |
Chemical signals and pathways in immune system |
| Track 1-3: |
Veterinary immunology |
| Track 1-4: |
Defense mechanisms: Molecular and functional aspects |
| Track 1-5: |
Clinical immunomics |
| Track 2: Innate and Adaptive Immune System |
| Track 2-1: |
Molecular pathways for human natural killer cells |
| Track 2-2: |
Structural and functional parameters of antimicrobial peptides (AMPs) |
| Track 2-3: |
Selective control mechanisms of AMPs |
| Track 2-4: |
Innate-adaptive interactions |
| Track 2-5: |
Approaches to study innate immunity |
| Track 3: Inflammatory/Autoimmune Diseases |
| Track 3-1: |
Organ-specific autoimmune disorders |
| Track 3-2: |
Major histocompatibility complex classes |
| Track 3-3: |
Role of Th17 cells and their importance |
| Track 3-4: |
Autoimmunity and inflammation: Metabolic disorders |
| Track 3-5: |
Systemic lupus erythematosus |
| Track 3-6: |
Immune responses in arthritis |
| Track 3-7: |
Multiple sclerosis |
| Track 4: Immunomodulation and Immunotherapy |
| Track 4-1: |
Stem cell therapy |
| Track 4-2: |
Alternative targets for immunointervention |
| Track 4-3: |
Clinical strategies to induce transplantation tolerance |
| Track 4-4: |
Gene therapy for autoimmune diseases |
| Track 4-5: |
Induced immunosuppression therapy |
| Track 5: Immunology of Major Diseases |
| Track 5-1: |
Hepatitis |
| Track 5-2: |
Tuberculosis |
| Track 5-3: |
Influenza |
| Track 5-4: |
HIV/AIDS |
| Track 5-5: |
Malaria |
| Track 5-6: |
Human papilloma virus |
| Track 5-7: |
Diabetes |
| Track 6: Metastasis and Cancer Therapy |
| Track 6-1: |
Tumorigenesis and tumor suppression or cancer immune prevention |
| Track 6-2: |
Epithelial stem cell cancer |
| Track 6-3: |
Interplay of cancer stem cells and metastasis |
| Track 6-4: |
Advances in imaging and detection of cancer stem cells and metastatic precursors |
| Track 6-5: |
Model studies for hematopoietic microenvironments |
| Track 6-6: |
Genetic and epigenetic regulation of cancer cells |
| Track 6-7: |
Cancer surveillance |
| Track 7: Vaccines in Immunology: New Insights and Development |
| Track 7-1: |
Recombinant vaccines and immunotherapeutics |
| Track 7-2: |
Cancer vaccines |
| Track 7-3: |
Bacterial and viral vaccines |
| Track 7-4: |
HIV vaccines |
| Track 7-5: |
T- Cell vaccines |
| Track 7-6: |
Synthetic vaccines |
| Track 7-7: |
Contraceptive vaccines |
| Track 7-8: |
Anti-inflammatory drugs and antiretroviral therapy
|
| Track 8: Emerging Issues in Immunology Research |
| Track 8-1: |
Osteoimmunology |
| Track 8-2: |
Nano-medicine immunology |
| Track 8-3: |
Mucosal immunology and translational immunology |
| Track 8-4: |
Autophagy in immune regulation |
| Track 9: Biomarkers and Techniques in Immunology |
| Track 9-1: |
RISET biomarkers |
| Track 9-2: |
ITN biomarkers |
| Track 9-3: |
Hybridoma technology |
| Track 9-4: |
Assays for immunology |
| Track 9-5: |
Immunophenotyping: Flow cytometry and immunoelectrophoresis |
RSS
Facebook
LinkedIn
Twitter
Blog